Close

Evolus (EOLS) Reports Prelim Q4 Revenue of $34.7M

Go back to Evolus (EOLS) Reports Prelim Q4 Revenue of $34.7M

Business Update Support Positive Thesis on Evolus (EOLS), Guidance Looks Conservative, Reiterate Overweight - Cantor Fitzgerald

January 26, 2022 2:30 PM EST

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $20.00 price target on Evolus (NASDAQ: EOLS), following the company's recent business update.

The analyst quotes: "Today (1/26), EOLS provided a business update that supports our positive investment thesis on the stock. The company: 1) exceeded revenue... More